Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma

International Journal of Cancer

Volumn 74, Issue 4, 1997, Pages 464-469

  Maelandsmo, Gunhild Mari ^a   FlØrenes, Vivi Ann ^b   Mellingsaetr, Turid ^a   Hovig, Eivind ^a   Kerbel, Robert S ^b   Fodstad, Øystein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOPROTEIN;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; METASTASIS; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; CALCIUM-BINDING PROTEINS; CELL LINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MELANOMA; MULTIGENE FAMILY; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030767388     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9     Document Type: Article

References (35)

1. AMBARTSUMIAN, N.S., GRIGORIAN, M.S., LARSEN, I.F., KARLSTRØM, O., SIDENIUS, N., RYGAARD, J., GEORGIEV, G. and LUKANIDIN, E., Metastasis of mamary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene, 13, 1621-1630 (1996).
2. AMBARTSUMIAN, N.S., TARABYKINA, S., GRIGORIAN, M.S., TULCHINSKY, E., HULGAARD, E., GEORGIEV, G. and LUKANIDIN, E., Characterization of two splice variants of metastasis-associated human mts1 gene. Gene, 159, 125-130 (1995).
3. BARRACLOUGH, R., SAVIN, J., DUBE, S.K. and RUDLAND, P.S., Molecular cloning and sequence of the gene for p9Ka. A cultured myoepithelial cell protein with strong homology to S-100, a calcium-binding protein. J. mol. Biol., 198, 13-20 (1987).
4. BRESLOW, A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172, 902-908 (1970).
5. CHO, K.H., HASHIMOTO, K., TANIGUCHI, Y., PIETRUK, T., ZARBO, R.J. and AN, T., Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer, 66, 765-771 (1990).
6. CHURCH, G.M. and GILBERT, W., Genomic sequencing. Proc. nat. Acad. Sci. (Wash.), 81, 1991-1995 (1984).
7. CLARK, W.H., JR., ELDER, D.E., GUERRY, D.I., EPSTEIN, M.N., GREENE, M.H. and VAN HORN, M., A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol., 15, 1147-1165 (1984).
8. COCHRAN, A.J., LU, H.F., LI, P.X., SAXTON, R. and WEN, D.R., S-100 protein remains a practical marker for melanocytic and other tumours. Melanoma Res., 3, 325-330 (1993).
9. DAVIES, B.R., DAVIES, M.P., GIBBS, F.E., BARRACLOUGH, R. and RUDLAND, P.S., Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene, 8, 999-1008 (1993).
10. DAVIES, M.P., RUDLAND, P.S., ROBERTSON, L., PARRY, E.W., JOLICOEUR, P. and BARRACLOUGH, R., Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene, 13, 1631-1637 (1996).
11. DORIN, J.R., EMSLIE, E. and VAN HEYNINGEN, V. Related calcium-binding proteins map to the same subregion of chromosome 1q and to extended region of synteny on mouse chromosome 3. Genomics, 8, 420-426 (1990).
12. 2+-binding protein family. Genes Develop., 3, 1086-1093 (1989).
13. ELDER, D.E., RODECK, U., THURIN, J., CARDILLO, F., CLARK, W.H., STEWART, R. and HERLYN, M., Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res., 49, 5091-5096 (1989).
14. FEINBERG, A.P. and VOGELSTEIN, B., A technique for radio labeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13 (1983).
15. FLØRENES, V.A., HOLM, R., MYKLEBOST, O., LENDAHL, U. and FODSTAD, Ø., Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res., 54, 354-356 (1994).
16. GAYNOR, R., HERSCHMAN, H.R., IRIE, R., JONES, P., MORTON, D. and COCHRAN, A., S100 protein: a marker for human malignant melanomas? Lancet, 1, 869-871 (1981).
17. GRIGORIAN, M., AMBARTSUMIAN, N., LYKKESFELDT, A.E., BASTHOLM, L., ELLING, F., GEORGIEV, G. and LUKANIDIN, E., Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int. J. Cancer, 67, 831-841 (1996).
18. HERLYN, M., Human melanoma: development and progression. Cancer Metastasis Rev., 9, 101-112 (1990).
19. HERLYN, M., THURIN, J., BALABAN, G., BENNICELLI, J.L., HERLYN, D., ELDER, D.E., BONDI, E., GUERRY, D., NOWELL, P., CLARK, W.H. and KOPROWSKI, H., Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res., 45, 5670-5676 (1985).
20. HILT, D.C. and KLIGMAN, D., The S-100 protein family: a biochemical and functional overview. In: C.W. Heizmann (ed.). Novel calcium-binding proteins: Fundamentals and clinical implications, pp. 65-103, Springer, Berlin (1991).
21. HOLZMANN, B., BRÖCKER, E.B., LEHMANN, J.M., RUITER, D.J., SORG, C., RIETHMÜLLER, G. and JOHNSON, J.P., Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int. J. Cancer, 39, 466-471 (1987).
22. ILG, E.G., SCHÄFER, B.W. and HEIZMANN, C.W., Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer, 68, 325-332 (1996).
23. ISOBE, T. and OKUYAMA, T., The amino-acid sequence of the α-subunit in bovin brain S-100 protein. Europ. J. Biochem., 89, 379-388 (1981).
24. JEUNG, E.B., KRISINGER, J., DANN, J.L. and LEUNG, P.C., Molecular cloning of the full-length cDNA encoding the human calbindin-D9k. FEBS Lett., 307, 224-228 (1992).
25. KLIGMAN, D. and HILT, D.C., The S100 protein family. Trends biochem. Sci., 13, 437-443 (1988).
26. LEE, S.W., TOMASETTO, C., SWISSHELM, K., KEYOMARSI, K. and SAGER, R., Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc. nat. Acad. Sci. (Wash.), 89, 2504-2508 (1992).
27. MAELANDSMO, G.M., HOLM, R., FODSTAD, Ø, KERBEL, R.S. and FLØRENES, V.A., The cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions. Amer. J. Pathol., 149, 1813-1822 (1996a).
28. MAELANDSMO, G.M., HOVIG, E., SKREDE, M., ENGEBRAATEN, O., FLØRENES, V.A., MYKLEBOST, O., GRIGORIAN, M., LUKANIDIN, E., SCANLON, K.J. and FODSTAD, Ø., Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res., 56, 5490-5498 (1996b).
29. MOORE, B.W., A soluble protein characteristic of the nerve system. Biochem. biophys. Res. Comm., 19, 739-744 (1965).
30. MORII, K., TANAKA, R., TAKAHASHI, Y. and KUWANO, R., Cloning of cDNAs encoding S-100 α and β subunits and their differential expression in human tumor cell lines. J. Neurosci. Res., 32, 27-33 (1992).
31. PEDROCCHI, M., SCHÄFER, B.W., MUELLER, H., EPPENBERGER, U. and HEIZMANN, C.W., Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int. J. Cancer, 57, 684-690 (1994).
32. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual, (2nd ed.). Cold Spring Harbor Laboratory, New York (1989).
33. SCHÄFER, B.W. and HEIZMANN, C.W., The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci., 21, 134-140 (1996).
34. WETERMAN, M.A., STOOPEN, G.M., VAN MUIJEN, G.N., KUZNICKI, J., RUITER, D.J. and BLOEMERS, H.P., Expression of calcydic in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res., 52, 1291-1296 (1992).
35. WETERMAN, M.A., VAN MUIJEN, G.N., BLOEMERS, H.P. and RUITER, D.J., Expression of calcyclin in human melanocytic lesions. Cancer Res., 53, 6061-6066 (1993).